Elicio Therapeutics Management
Management criteria checks 3/4
Elicio Therapeutics' CEO is Bob Connelly, appointed in Oct 2018, has a tenure of 6.08 years. total yearly compensation is $678.30K, comprised of 73.5% salary and 26.5% bonuses, including company stock and options. directly owns 0.44% of the company’s shares, worth €216.95K. The average tenure of the management team and the board of directors is 3.3 years and 3.2 years respectively.
Key information
Bob Connelly
Chief executive officer
US$678.3k
Total compensation
| CEO salary percentage | 73.5% |
| CEO tenure | 6.1yrs |
| CEO ownership | 0.4% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$47m |
| Jun 30 2024 | n/a | n/a | -US$39m |
| Mar 31 2024 | n/a | n/a | -US$39m |
| Dec 31 2023 | US$678k | US$499k | -US$35m |
| Sep 30 2023 | n/a | n/a | -US$33m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | US$1m | US$475k | -US$28m |
| Sep 30 2022 | n/a | n/a | -US$28m |
| Mar 31 2022 | n/a | n/a | -US$27m |
| Dec 31 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$872k | US$450k | -US$16m |
Compensation vs Market: Bob's total compensation ($USD678.30K) is above average for companies of similar size in the German market ($USD474.54K).
Compensation vs Earnings: Bob's compensation has been consistent with company performance over the past year.
CEO
Bob Connelly (64 yo)
6.1yrs
Tenure
US$678,300
Compensation
Mr. Robert T. Connelly, also known as Bob, has been Chief Executive Officer and Director of Elicio Therapeutics Inc. since October 2018 and serves as its President and has been its Principal Accounting Off...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 6.1yrs | US$678.30k | 0.44% € 217.0k | |
| Executive VP | 5.1yrs | US$673.82k | 0.30% € 147.7k | |
| Co-Founder | no data | no data | no data | |
| Senior Vice President of Operations & Human Resources | 4.8yrs | no data | no data | |
| Chief Scientific Officer | 2.8yrs | no data | 0% € 0 | |
| General Counsel | 1.8yrs | no data | no data | |
| Senior Vice President of Clinical Development | 3.8yrs | no data | no data | |
| VP & Head of Regulatory Affairs | 2.5yrs | no data | no data | |
| Senior Vice President of Biometrics | 1.8yrs | no data | no data |
3.3yrs
Average Tenure
58yo
Average Age
Experienced Management: 9HA's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 6.1yrs | US$678.30k | 0.44% € 217.0k | |
| Co-Founder | no data | no data | no data | |
| Independent Chairman & Member of Scientific Advisory Board | 7.8yrs | US$96.05k | 0% € 0 | |
| Independent Director | 1.4yrs | US$101.02k | 0.017% € 8.6k | |
| Independent Director & Member of Scientific Advisory Board | 6.8yrs | US$63.26k | 0% € 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 1.4yrs | US$2.43m | 1.21% € 602.9k | |
| Independent Director | 4.3yrs | US$71.59k | 0% € 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 2.1yrs | US$48.68k | 17.78% € 8.8m | |
| Independent Director | 1.4yrs | US$91.22k | 0% € 0 | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.2yrs
Average Tenure
65yo
Average Age
Experienced Board: 9HA's board of directors are considered experienced (3.2 years average tenure).